peak blood level 2-34 ,mol/l, 80-128 min after dosing) than when administered on an empty stomach (mean peak blood level 5 08 Htmol/l, 48-64 min after dosing). Blood cimetidine concentration correlated significantly (p < 0 01) with percentage inhibition of acid output and the calculated concentration resulting in 50% inhibition of gastric acid secretion (IC50) was 1 6 pmol/l. Secretion of gastrin in response to food was unaffected by cimetidine. The results suggest that 200 mg cimetidine effectively inhibits food-stimulated acid secretion and that the bioavailability of the drug may be affected by the timing of dosage in relation to meals. No unwanted effects were observed.
Cimetidine is a new histamine H2-receptor antagonist which differs from metiamide by having a cyanoguanidine group in place of the thiourea group in the side-chain (Black et al., 1972; Brimblecombe et al., 1975) (Fig. 1) . Preliminary studies have suggested that cimetidine is slightly more potent than metiamide in inhibiting human gastric acid secretion stimulated by pentagastrin or histamine (Burland, et al., 1975) . We have used in vivo intragastric titration to study the effect of oral cimetidine on foodstimulated gastric acid secretion in normal subjects.
Methods
Food-stimulated gastric acid secretion was measured using a modified form of the technique described by Fordtran and Walsh (1973) .
All the meals were prepared in advance from the same batch of food, homogenised, and stored at -20°C. Each meal contained 100 g lean roast beef, 30 g bread, 10 g butter, and 1 g salt made up to 450 ml with water. The composition of the meal (derived from McCance and Widdowson, 1960) was protein 29-0 g, carbohydrate 15-8 g, fat 23-9 g, energy value 1,667 kJ. The meals were warmed to 37°C and the pH adjusted to 5 50 with less than 1 ml concentrated hydrochloric acid immediately before use.
The subjects fasted overnight and on the day of the test were intubated with a double lumen 14 FR nasogastric tube (Salem Sump, Sherwood Medical Industries Inc., Argyle) the tip of which was positioned under x-ray control to the most dependent part of the stomach. After emptying the stomach, the test meal was instilled through the larger lumen of the tube during five minutes. The experiments continued until it became impossible to aspirate at least 50 ml gastric contents despite turning the subject from side to side.
Throughout each study the gastric contents were mixed by the aspiration and return of 50 ml of the meal every 15 seconds. In addition, the subjects moved from the supine to the left or (,umol/l) was determined on duplicate samples using high pressure liquid chromatography (Smith Kline Corporation, Philadelphia). Plasma gastrin was measured by radioimmunoassay using an antibody raised to synthetic human gastrin I conjugated to bovine serum albumin by carbodiimide. The antibody reacted 100% with human little gastrin and 75 % with human big gastrin, reacting preferentially with the C-terminal end of the molecule. There was less than 1 % cross-reactivity with cholecystokinin or pentagastrin. The assay used gastrin-free plasma prepared by affinity chromatography to make up the standards (MRC 68/439) and could detect differences of 2 pg/ml gastrin I with 95 % confidence.
Six normal subjects (mean age 315 yr, SEM + 3 5, range 20-43; mean weight 78-2 kg, SEM ± 5 4, range 53-88) were each studied on two occasions, no more than two days apart. One normal female subject was studied twice without medication in order to check the reproducibility of the method. The six males received either cimetidine solution (200 mg in 4 ml), or placebo (water, 4 ml) in random order and without knowledge of the sequence of treatment. The pH of the cimetidine solution was 5 30 and titration of 4 ml of the solution to pH 5 50 required only 0-02 mmol of sodium hydroxide. Three subjects received the test substance mixed with the meal; in the other three the placebo or cimetidine were placed in the stomach in 50 ml water 32 min before the meal. In these subjects the stomach was emptied before the administration of the test substance and not immediately before the infusion of the test meal.
Haematological and biochemical safety profiles were performed before and after the studies. All subjects gave their informed consent to the procedures, which were approved by the appropriate ethical committees.
Results
The adjustments of the rate of the sodium bicarbonate infusion were successful in maintaining the intragastric pH close to the set level of 5 50. Figure 2 shows that the pH of the gastric aspirates obtained at the end of each 16 min period was between 5 45 and 5 55 in 47 % of these samples, and between 5 35 and 5 65 in 84%. Turning the subject from side to side was important in ensuring adequate mixing of gastric contents, the pH dropping by 0-10-0-20 after each turn; these swings of pH were easily corrected by temporarily increasing the rate of the bicarbonate infusion (Fig. 3) . Replicate studies in the one subject without medication (Fig. 4) showed a good correlation for the rate of acid secretion (r = 0 99, p < 001) and for the amount of acid secreted (slope = 0-87). In the six male subjects the volume of bicarbonate infused averaged 82-6 ± 9.5 ml 2 (SEM) of the 666 mmol/l solution in the placebo experiments and 62-5 ± 8-9 ml of the 333 mmol/l solution in the cimetidine experiments.
The cumulative acid secretion of each subject is shown in Fig. 5 . lEAL subjects during all the periods of observation (p < 0 01; analysis of variance). In the three subjects given cimetidine with food, mean acid secretion was decreased by 57% of the control output during the 96 min after the drug, and by 60% during 112 min in the two subjects in whom measurements were possible for a longer time. When cimetidine was given 32 min before the meal, mean acid secretion was decreased by 67% of control output at 96 min (three subjects) and by 65 % at 112 min (two subjects).
Blood cimetidine levels were markedly affected by the time of administration of the drug in relation to the meal. Peak concentrations of the drug were 40. approximately twice as high and occurred earlier when the drug was given before the meal. At 80 min after the meal the cimetidine blood levels were similar in the two groups of subjects, but appeared to be declining in those given the drug before the meal, while the concentration curves in the other group suggest the formation of a plateau (Fig. 6 ).
In Fig. 7 the percentage inhibition of acid secretion in the six subjects is plotted against their calculated average blood cimetidine levels for each 16 min period. In all three subjects who received cimetidine with the meal, the inhibition of acid output during the first 16 min of the test appeared to be inappropriately high in relation to the low blood levels of the drug at that time. Regression analysis was therefore performed omitting those three results.
In both groups of subjects there was significant correlation between cimetidine blood level and percentage inhibition of acid output (drug before meal r = 0 40, p = 005; drug with meal r = 0-72, p < 001). Analysis of variance showed no significant difference between the slopes of the two regression lines. The regression line in Fig. 7 has therefore been calculated using the combined data of both groups, and it shows significant correlation between blood concentrations and response (r = 0 56, p < 0 01). The calculated blood concentration of cimetidine resulting in 50% inhibition of foodstimulated acid secretion (IC50) is 1-6 ,umol/l.
Immunoreactive plasma gastrin levels increased in response to the meal in both groups of subjects. Administration of cimetidine had no effect on the secretion of gastrin (Fig. 8) . Cimetidine did not appear to alter the rate of gastric emptying, as estimated by the length of time after the meal during which it was possible to aspirate 50 ml of the gastric contents. No unwanted clinical or laboratory effects were observed in any subject.
Discussion
The technique of in vivo intragastric titration (Fordtran and Walsh, 1973) was used in this 2* study because it is eminently suitable for measuring the effects of ingested drugs on gastric acid secretion stimulated by food. As the gastric contents are left in situ and gastric secretion is not stimulated by pharmacological agents, the effects of medication, the response of gastrointestinal polypeptide hormones, and the absorption characteristics of drugs can all be studied in conditions which approximate to the physiological. This study confirms the original observations of Fordtran and others (Fordtran and Walsh, 1973; , submitted for publication) that the technique is easy to perform, is well tolerated by the subjects, and gives reproducible results in replicate experiments. We were not able to measure acid secretion beyond 96 to 128 min after the instillation of the 450 ml meal into the stomach. The 600 ml meal used by Fordtran and Walsh (1973) tions to be made during a longer period and therefore the large volume may be preferable for more prolonged studies of drug action. By using a more concentrated sodium bicarbonate solution with the placebo, the volumes of alkali infused were comparable in the paired experiments.
Results of this study show that 200 mg cimetidine instilled into the stomach significantly inhibited acid secretion in every subject investigated. The effect was apparent in all six subjects within 16 min of the meal, and there was no diminution of drug action in the 96 to 128 min after the meal. The present results are compared in Table 2 with four other studies reporting the effect of H2-receptor antagonists on food-stimulated acid secretion. The ID50 of cimetidine (the dose required to produce 50 % inhibition) against histamine stimulated acid secretion is lower than the ID50 of metiamide in several animal models (Brimblecombe et al., 1975) , but comparisons with other human studies must be made with caution, partly because of variations in the methods used by different investigators, and partly because patients with duodenal ulcer may secrete at a much higher rate, and at a higher fraction of the maximal histamine response, than normal subjects (Fordtran and Walsh, 1973) .
The IC50 of intravenously administered cimetidine against histamine-or pentagastrin-stimulated gastric acid secretion in man has been reported to be 2-0 ,tmol/l (Burland et al., 1975) , but the present study gives a slightly lower figure of 1-6 ,umol/I for foodstimulated secretion and oral cimetidine.
Our results show that cimetidine absorption from the gut is greatly affected by the timing of the dose in relation to the meal. Giving the drug before the Table 2 Comparison of effects of metiamide and cimeridine on food-stimulated acid secretion (no. = nu-n5er of subjects at each dose, or time of dose) meal resulted in peak blood concentrations of 3 to 7 ttmol/l 48 min after the dose, but the levels fell rapidly to approximately 2 ,tmol/l 128 min after administration. Cimetidine is thought to be absorbed in the small intestine and it is likely that the rapid absorption was produced by prompt gastricemptying of the 50 ml of fluid instilled 32 min before the meal. The rapid absorption and high blood levels of the drug when given before the meal were reflected in a more profound inhibition of early acid output (Table 1) but at this stage post-prandial acid secretion is buffered by the meal itself (LennardJones and Babouris, 1965; Pounder et al., 1976) . When cimetidine is taken with a meal, bioavailability of the drug may be prolonged because of slower absorption from the gut. The inhibition of acid secretion might therefore be delayed until late after the meal, when the buffering capacity of the ingested food has been diminished by gastric emptying. Similar absorption curves are likely to occur with post-prandial medication, although this study does not provide data on this point. Clearly, the timing of medication in relation to food may affect the therapeutic efficacy of cimetidine and it needs to be carefully defined in further pharmacological and clinical studies (Pounder et al., 1976) .
When cimetidine was administered with the meal, a much greater inhibition of acid output was recorded during the first 16 min after food (Fig. 7 , open circles) than expected from the data on blood level response obtained during the remainder of the study. There are several possible explanations of this apparent discrepancy. Firstly, measurements performed when the rate of acid secretion was changing rapidly may have been subject to experimental error. However, inhibition of acid secretion during the first 16 min after the meal was consistent with the observed relationship of blood level and response in the other subjects who were dosed 32 min before food. Moreover, we have not recorded similar discrepancies in other studies using this technique. Secondly, it is possible that the meal did not maximally stimulate acid secretion during the first minutes of the study: there is evidence that cimetidine more easily inhibits basal than stimulated secretion (Henn et al., 1975) . The results during the 16 min after the meal in the other group of subjects are against this explanation (Fig. 7, open triangles) . Lastly, it is possible that, immediately after intragastric instillation of the drug, a steep concentration gradient exists between the gastric contents and the mucosa, resulting in local absorption of cimetidine. At that time, systemic blood levels would not reflect the concentration of cimetidine in the vicinity of the parietal cells, but this idea needs further experimental testing.
The normal increase of circulating immunoreactive gastrin concentration after a meal was unaffected by cimetidine, indicating that, in common with other histamine H2-receptor antagonists (Mainardi et al., 1974) , cimetidine does not inhibit acid output by interfering with the secretion of gastrin.
Cimetidine has been shown to be a reliable and potent antisecretory drug, which is free of unwanted effects in acute studies in man. As cimetidine is a non-thiourea histamine H2-receptor antagonist, it is to be hoped the risk of producing bone marrow depression has been eliminated. Clinical evaluation of the compound is awaited with interest.
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